Cargando…

Immune Characteristics of IgA Nephropathy With Minimal Change Disease

Background: IgA nephropathy (IgAN) has a high degree of heterogeneity in clinical and pathological features. Among all subsets of IgAN, the pathogenesis of IgAN with minimal change disease (MCD-IgAN) remained controversial. Methods: We analyzed the clinical and pathological characteristics of MCD-Ig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huixian, Lu, Wanhong, Li, Haiyun, Liu, Xiaoling, Zhang, Xue, Xie, Liyi, Lan, Ping, Yu, Xiaoyang, Dai, Yinjuan, Xie, Xinfang, Lv, Jicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716750/ https://www.ncbi.nlm.nih.gov/pubmed/34975488 http://dx.doi.org/10.3389/fphar.2021.793511

Ejemplares similares

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine
por: Xie, Xinfang, et al.
Publicado: (2021)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort
por: Li, Huixian, et al.
Publicado: (2022)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
por: Huang, Xin, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
por: Li, Honglian, et al.
Publicado: (2020)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
por: Liu, Caiqiong, et al.
Publicado: (2021)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022
por: Guo, Yun, et al.
Publicado: (2023)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
por: Luo, Mian-Na, et al.
Publicado: (2023)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
por: Zhao, Lijuan, et al.
Publicado: (2023)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
por: Han, Shisheng, et al.
Publicado: (2021)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Case Report: Coexistence of Anti-Glomerular Basement Membrane Disease, Membranous Nephropathy, and IgA Nephropathy in a Female PatientWith Preserved Renal Function
por: Qu, Wei, et al.
Publicado: (2022)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy
por: Luo, Mian-Na, et al.
Publicado: (2023)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Characterization of patients with IgA nephropathy with and without associated minimal change disease
por: Guo, Wei-yi, et al.
Publicado: (2023)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Adult-onset Minimal Change Disease with IgA Nephropathy and Hepatitis C
por: Chowdhury, Waliul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8nqlat6ut1ad9pujbq6cvhqhok